RxDoctor Payments Data

Liliana Torrealba, PA

Medical · Jacksonville, FLNPI 1306242748

Payments from drug & device makers

$6,059in general payments, 2019–2025

Across 170 payments — averaging $35.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2K
  • Boston Scientific$517
  • Amgen$507
  • Johnson & Johnson$488
  • Boehringer Ingelheim$476
  • Medtronic$416
  • plus $2K from 21 others

What the payments were for

  • Travel & lodging$4578%
  • Food & beverage$5,47290%
  • Education$1302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,059 in reported general payments places this provider in the 85th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$15,019
Medicare patients
185
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$53,695
JardianceEmpagliflozin39$35,653
EntrestoSacubitril/Valsartan19$18,708
BrilintaTicagrelor14$6,517
Ranolazine ErRanolazine11$1,972
ClopidogrelClopidogrel Bisulfate107$967
Rosuvastatin Calcium54$584
Metoprolol Succinate47$564
Atorvastatin Calcium60$481
Losartan Potassium54$402
Carvedilol37$399
Valsartan16$309
Amlodipine Besylate74$264
Ezetimibe15$186
Lisinopril20$137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$83$53,69565 claims
Boehringer IngelheimJardiance$476$35,65339 claims
NovartisEntresto$190$18,70819 claims
AstraZenecaBrilinta$100$6,51714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,031 medical providers in Florida.

Other medical in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →